Document is current
Any future updates will be listed below
-
Authors
Krasselt, Marco https://orcid.org/0000-0002-1842-0754
Friedrich, Kathleen
Braune, Laurin
Rothe, Kathrin
Blüher, Matthias https://orcid.org/0000-0003-0208-2065
Kovacs, Peter https://orcid.org/0000-0002-0290-5423
Dietrich, Arne
Rossol, Manuela
Stumvoll, Michael https://orcid.org/0000-0001-6225-8240
Wagner, Ulf
- License Information
-
More Information
Article History
Received: 8 October 2025
Revised: 27 March 2026
Accepted: 10 April 2026
First Online: 24 April 2026
Competing interests
: MB received honoraria as a consultant and speaker from Abbott, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Eli Lilly, Novo Nordisk, and Sanofi. All other authors declare no conflicts of interest related to this manuscript.
: All procedures performed in this survey were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Data obtained in this study did not interfere with the course of treatment for patients included.
: Informed consent was obtained from all individual participants included in the study.
